Pitt Shield

Focused Ultrasound as Rescue Treatment of Essential Tremor After Deep Brain Stimulation: 2 Case Reports.

Authors: Gonzalez A, Tardáguila M, Ispierto L, Muñoz J, Gea M, Jaumà S, Plans G, Álvarez R, Vilas Rolán D

Approximately 25% to 55% of patients with essential tremor will eventually develop medication-refractory tremor. Currently, the standard surgical treatment for this condition is deep brain stimulation (DBS) of the ventralis intermedius nucleus of the thalamus and, more recently, the posterior subthalamic area. However, MRI-guided focused ultrasound (FUS) thalamotomy has shown promising results in improving tremor in patients with refractory essential tremor. We present 2 cases of patients with a disabling action tremor, recurring after DBS. A 55-year-old right-handed male and a 52-year-old woman presented with bilateral medically refractory action tremor, which began in their second decade of life. Both underwent bilateral DBS-ventralis intermedius, with the first patient showing a good initial response but the second patient showing a suboptimal response within the first year after DBS. In both cases, the DBS system was removed and the patients subsequently underwent left-sided FUS thalamotomy with a dramatic improvement of their tremor. These cases demonstrate the feasibility of performing FUS thalamotomy as a rescue treatment for disabling tremor after DBS.

Introduction

Purpose Thermal ablation
Study Objective To demonstrate the feasibility of MRI-guided focused ultrasound thalamotomy as a rescue treatment for disabling tremor recurring after deep brain stimulation.
Animal model / Human subject Human (Homo sapiens); strain: N/A; 55-year-old male and 52-year-old female
Disease model Essential tremor (medication-refractory)
MRI or image guidance method 3 T MRI (GE)
Targeted brain region(s) Thalamus

Outcomes and Safety

Summary of Outcomes Left sided FUS thalamotomy resulted in marked improvement of disabling action tremor in 2 patients with recurrent tremor after DBS failure, with sustained benefit at follow up
Duration of biological effect 6 months; 1 year
Safety-related matter The authors state FUS thalamotomy was a safe and effective rescue treatment in these two cases with no specific adverse events reported; they advise complete removal of the DBS system and careful lead localization before FUS to avoid potential cavitation and call for larger studies to confirm long‑term safety.

Brain Region

Ultrasound Parameters

Ultrasound instrument ExAblate Neuro (InSightec)
Duration of a single FUS session 90 s (case 1); 33 s (case 2)
Focal Characteristics Focal depth: None; Focal length: None; Aperture size: None
Treatment frequency Single session

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search